Item 7.01 Regulation FD Disclosure.

On April 17, 2020, the SEC announced that it has suspended trading in the Company's common stock for period from April 17, 2020 through April 30, 2020 due to questions and concerns regarding the adequacy and accuracy of publicly available information in the marketplace concerning the Company including (1) press releases, since at least March 11, 2020, about the Company's orders of COVID-19 tests for overseas customers and (2) press releases and other publicly disseminated statements, since at least March 18, 2020, about the existence of customer orders.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.






 2

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

PreCheck Health Services, Inc.

Date: April 20, 2020 By:   /s/ Justin E. Anderson
                           Justin E. Anderson
                           Chief Executive Officer







 3

© Edgar Online, source Glimpses